Cleared Traditional

Neuromuscular Transmission Monitor TOF3D

May 2022
Decision
274d
Days
Class 2
Risk

About This 510(k) Submission

K212434 is an FDA 510(k) clearance for the Neuromuscular Transmission Monitor TOF3D, a Stimulator, Nerve, Peripheral, Electric (Class II — Special Controls, product code KOI), submitted by MIPM Mammendorfer Institut f?r Physik und Medizin GmbH (Mammendorf, DE). The FDA issued a Cleared decision on May 5, 2022, 274 days after receiving the submission on August 4, 2021. This device falls under the Anesthesiology review panel. Regulated under 21 CFR 868.2775.

Submission Details

510(k) Number K212434 FDA.gov
FDA Decision Cleared SESE
Date Received August 04, 2021
Decision Date May 05, 2022
Days to Decision 274 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code KOI — Stimulator, Nerve, Peripheral, Electric
Device Class Class II — Special Controls
CFR Regulation 21 CFR 868.2775

Similar Devices — KOI Stimulator, Nerve, Peripheral, Electric

All 27
Neuromuscular Transmission Monitor TOF3D (2510091)
K250887 · MIPM Mammendorfer Institut f?r Physik und Medizin GmbH · Oct 2025
WiTOF
K243339 · Idmed · Jun 2025
iTOF?
K242525 · Nerbio Medical Software Platforms, Inc. · Dec 2024
Tetragraph Neuromuscular Transmission Monitor
K220530 · Senzime AB · Aug 2022
Life Scope PT BSM-1700 Series Bedside Monitor
K220976 · Nihon Kohden Corporation · Jul 2022
Life Scope PT BSM-1700 Series, AY Series, Data Acquisition Unit, LIFE SCOPE BSM 6000 SERIES BEDSIDE MONITORING SYSTEM, Nihon Kohden CSM-1901 BEDSIDE MONITORING SYSTEM
K213316 · Nihon Kohden Corporation · Dec 2021